In this analysis, ERBB2 variants were more frequent in cases with MPN compared to the control cohort (8.9% vs. 5.2%, p = 0.040), confirming the small but significant MPN risk associated with variants in this gene (Table 1). The gene discussed is ERBB2; the disease is myeloproliferative neoplasm.